Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clotting Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05879549
What this trial is testing

Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises Patient With Hemophilia

Who this might be right for
Hemophilia AHemophilia B
Bahçeşehir University 46
Large-scale testing (Phase 3)Ended earlyNCT01445197
What this trial is testing

Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development

Who this might be right for
Hemophilia A
CSL Behring 1
Large-scale testing (Phase 3)UnknownNCT00396760
What this trial is testing

Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery

Who this might be right for
Bleeding and Cardiac SurgeryAllogeneic Blood TransfusionAortic Valve Replacement+1 more
German Heart Center 220
Early research (Phase 1)Study completedNCT00816660
What this trial is testing

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

Who this might be right for
Von Willebrand Disease
Baxalta now part of Shire 32
Testing effectiveness (Phase 2)Study completedNCT00475423
What this trial is testing

MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 122
Testing effectiveness (Phase 2)Ended earlyNCT03700723
What this trial is testing

Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy

Who this might be right for
Coagulopathy
Entegrion, Inc. 4
Not applicableLooking for participantsNCT07012291
What this trial is testing

Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™

Who this might be right for
Coagulation
Perosphere Technologies Inc. 150
Testing effectiveness (Phase 2)WithdrawnNCT01121510
What this trial is testing

Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System

Who this might be right for
CoagulationTherapeutic UsesPharmacologic Actions
CardioDex 50
Not applicableStudy completedNCT06408324
What this trial is testing

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
European Research Consortium on ITP 275
Not applicableLooking for participantsNCT05022459
What this trial is testing

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

Who this might be right for
Hemophilia A
Wayne State University 72
Testing effectiveness (Phase 2)WithdrawnNCT03965624
What this trial is testing

Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT00945542
What this trial is testing

The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study)

Who this might be right for
Hemorrhagic ShockTrauma Coagulopathy
Sunnybrook Health Sciences Centre 70
Not applicableStudy completedNCT00210197
What this trial is testing

Hypercoagulability After Breast Cancer Surgery

Who this might be right for
Breast CancerBlood Coagulation Disorders
Institut Bergonié 48
Not applicableLooking for participantsNCT04421924
What this trial is testing

Periinterventional Coagulation Management of Patients Undergoing a TIPS

Who this might be right for
Liver Cirrhosis
Medical University of Graz 39
Large-scale testing (Phase 3)Looking for participantsNCT06700096
What this trial is testing

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

Who this might be right for
Hemophilia B
Biocad 24
Not applicableStudy completedNCT00705991
What this trial is testing

Validation of Thrombelastometry (ROTEM®)

Who this might be right for
Coagulation
University of Zurich
Large-scale testing (Phase 3)Study completedNCT00616460
What this trial is testing

ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding

Who this might be right for
Hematologic Diseases
HaEmek Medical Center, Israel 100
Very early researchStudy completedNCT05281718
What this trial is testing

Factor IX as Adjunctive Therapy to Emicizumab (EMIX)

Who this might be right for
Hemophilia A
Tulane University 12
Testing effectiveness (Phase 2)Study completedNCT00441090
What this trial is testing

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic
Eisai Inc. 64
Early research (Phase 1)Active Not RecruitingNCT05936359
What this trial is testing

Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms
Incyte Corporation 160
Next Page